Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xixuan Zhu
Institution:
Institute of Cancer Research
Observed institution:
Institute of Cancer Research
ORCID:
0000-0003-3477-3426
Observed ORCID:
0000-0003-3477-3426
OpenAlex ID:
A5023777446
The proteomic landscape of soft tissue sarcomas
2023
·
Jessica Burns
, Christopher P. Wilding
, et al.
·
Nature Communications
·
49
PDF
Short-duration preoperative endocrine therapy alters molecular profiles to predict favourable outcome in ER+/HER2+ early breast cancer: a POETIC translational study
2025
·
Milana Bergamino Sirvén
, Elena López-Knowles
, et al.
·
EBioMedicine
·
6
A Digital Environment for Multi-modal Relational Management, Representation, and Analysis of Cancer Clinical Studies
2026
·
Ferran Cardoso Rodriguez
, Xixuan Zhu
, et al.
·
medRxiv
PDF
Abstract P2-01-23: A 140-gene Machine Learning Classifier Predicts Survival and Response to Chemotherapy and Immunotherapy in 2500 TNBC
2025
·
Xixuan Zhu
, Orsolya Sipos
, et al.
·
Clinical Cancer Research
Abstract P1-11-14: Hormone receptor positive (ER+) HER2+ Lobular Breast Carcinoma: Molecular Response to Perioperative Endocrine Therapy and Clinical Outcomes in the POETIC Trial
2025
·
Milana Bergamino Sirvén
, Xixuan Zhu
, et al.
·
Clinical Cancer Research
Molecular profiling after short-term preoperative endocrine therapy to identify oestrogen receptor positive (ER+)/HER2+ early breast tumours with favourable prognosis.
2024
·
Milana Bergamino Sirvén
, Elena Lopez-Knowles
, et al.
·
Journal of Clinical Oncology
Abstract PS09-08: Genomic characterization of endocrine resistance in ER+HER2+ breast cancers in the POETIC Trial
2024
·
Maggie Chon U Cheang
, Xixuan Zhu
, et al.
·
Cancer Research
Abstract P2-03-08: Deconstructing the molecular characteristics of ER+ HER2+ early breast cancer in the POETIC trial using multiplex immunofluorescence and gene expression profiles
2023
·
Xixuan Zhu
, Hui Xiao
, et al.
·
Cancer Research
Abstract P2-03-07: Multi-parametric algorithm integrating on-treatment Ki67 value and standard clinicopathological variables to predict risk of recurrences for women > 70 years old with early ER+HER2- tumours in POETIC trial
2023
·
Maggie Chon U Cheang
, Monisha Dewan
, et al.
·
Cancer Research
Show more works
View as search
Works count:
9
Citation count:
55
H-index:
2
I10-index:
1
Year
Topic
Type